To Eris Pharma Australia
Aurobindo Pharma announced that Aurobindo Pharma (APL) has divested its step-down subsidiary, Aurobindo Pharma (Australia) to Eris Pharma Australia. APL will, however, under an agreement continue to manufacture and supply the products to Eris Pharma for Australian and New Zealand market over next few years. This divestment is in line with APL's strategy of focusing on US, EU and Key Emerging Markets. This subsidiary was not contributing any profit to Aurobindo.Powered by Capital Market - Live News
